Press Releases

MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients

MMI Earns Gold Edison Award for Symani, Recognized for Expanding Access to Life-Changing Surgical Treatment Options

MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study

MMI Introduces World’s First Microsurgical Suture for Robotics

MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference

MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani

MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential

MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients

MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery

MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery